Makobu Kimani
Biographic Data
| ID | 7729083 |
|---|---|
| NAME | Makobu Kimani |
| GIVEN NAMES | Makobu |
| FAMILY NAME | Kimani |
| SIGNATURE | KIMANI M |
| AFFILIATIONS | Kenya Medical Research Institute |
| ORCID | 0000-0001-9275-4018 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Active vaccine safety surveillance
Although active vaccine safety surveillance (VSS) can complement passive VSS while overcoming the inherent limitations of spontaneous safety monitoring, it remains rare in sub-Saharan Africa. We conducted post-authorization active VSS of COVID-19 vaccines in Kilifi, Kenya using a cohort event monitoring study design. Participants were followed weekly over 13 weeks for adverse events. A subset was followed daily for one week for solicited systemic…
Urchoice
No prominent works on this page.
Urchoice
Active vaccine safety surveillance
Although active vaccine safety surveillance (VSS) can complement passive VSS while overcoming the inherent limitations of spontaneous safety monitoring, it remains rare in sub-Saharan Africa. We conducted post-authorization active VSS of COVID-19 vaccines in Kilifi, Kenya using a cohort event monitoring study design. Participants were followed weekly over 13 weeks for adverse events. A subset was followed daily for one week for solicited systemic…
Adverse effect (1 work) · Cohort (1 work) · COVID-19 Impact on Reproduction (1 work) · Demography (1 work) · Demography (1 work) · Family medicine (1 work) · Gynecology (1 work) · HIV, Drug Use, Sexual Risk (1 work) · HIV/AIDS Research and Interventions (1 work) · Human immunodeficiency virus (HIV (1 work)